Abstract:Abstract Background: The past 20 years of translational oncology provide a framework in which the ability to eradicate cancer has increased in direct relation to our understanding of T cell biology. The cancer-killing functions of T cells are often compromised within tumors, allowing disease progression. Tumor-derived factors and the hostile microenvironment contribute to constraining of T cell effector functions and driving terminal differentiation. We previously identified that elevated extracellular K+ characteristics of the tumor microenvironment limits both TCR dependent activation and effector functions, while preserving coincidently preserving T cell stemness (Eil R, Nature 2016 & Science 2019). Despite these findings and the centrality of ion gradients to cellular physiology broadly, our understanding of T cell K+ transport remains rudimentary and cannot account for the pleiotropic role K+ abundance plays in antitumor immunity. In fact, little is known about what K+ transporters T cell express nor their functional regulation. Findings: Here, we report the canonical Na+-K+-ATPase to be intertwined with T cell metabolic homeostasis, memory formation, and antitumor activity and therefore an appealing avenue for T cell reprogramming. We first performed whole-transcriptomic sequencing of CD8+ memory subsets and found that components of the Na+-K+-ATPase were expressed at robust levels that were notably enriched in naïve and memory cells. Despite partially impairing Ca2+ influx, T cells genetically deficient for the Na+-K+-ATPase exhibited constitutive activity in both TCR and Akt-mTOR associated signaling pathways along with rapid acquisition of co-inhibitory surface receptors, mitotic arrest, and functional exhaustion. Mechanistically, we identified pathologic ROS accumulation as the driver of unregulated signaling and rapid exhaustion. In vivo, T cells lacking deficient in Na+-K+-ATPase activity failed to achieve proliferative burst following pathogen challenge and demonstrated severely compromised antitumor function. Our results support a model in which the Na+- K+- ATPase primarily functions in T cells to maintain ROS metabolism, thereby preventing its pathologic accumulation and preserving T cell stemness and antitumor potential. Conclusion: These results uncover a fundamental yet underappreciated aspect of T cell biology with translational implications for the ongoing development of cancer immunotherapies. Immediate applications include pharmacologic and genetic targeting of ion transporters in the setting of immune checkpoint blockade or T cell transfer therapies (i.e. CAR, TCR, TIL). Citation Format: Camille Collier, Matthew McWhorter, Kelly Wucherer, Chelsea Jenkins, Alexandra Bartlett, Robert Eil. T cell antitumor function requires potassium transport [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2023; Part 1 (Regular and Invited Abstracts); 2023 Apr 14-19; Orlando, FL. Philadelphia (PA): AACR; Cancer Res 2023;83(7_Suppl):Abstract nr 613.

T cell stemness and dysfunction in tumors are triggered by a common mechanism

In Vivo Functional Genomics Identifies Essentiality of Potassium Homeostasis in Medulloblastoma

STEM-26. BLOOD-TUMOR BARRIER IS COMPOSED OF MECHANOSENSING TUMOR CELLS THAT MASK THERAPEUTIC VULNERABILITY

Metabolic reprogramming in the tumor microenvironment: unleashing T cell stemness for enhanced cancer immunotherapy

Tumor-initiating Stem Cell Shapes Its Microenvironment into an Immunosuppressive Barrier and Pro-Tumorigenic Niche.

Abstract 613: T cell antitumor function requires potassium transport

T Cell Anergy, Exhaustion, Senescence, and Stemness in the Tumor Microenvironment

Extracellular acidosis restricts one-carbon metabolism and preserves T cell stemness

Metabolic Competition in the Tumor Microenvironment Is a Driver of Cancer Progression

Tumor-associated Macrophages Are Shaped by Intratumoral High Potassium Via Kir2.1.

Abstract A026: Lysosomal ion gradients are key determinants of T cell metabolism and function

T-cell exhaustion and stemness in antitumor immunity: Characteristics, mechanisms, and implications

A Reservoir of Stem-Like CD8 T Cells in the Tumor-Draining Lymph Node Maintains the Ongoing Anti-Tumor Immune Response

PD-1 controls differentiation, survival, and TCR affinity evolution of stem-like CD8+ T cells

Tumor-Reactive CD8+ T Cells Enter a TCF1+PD-1- Dysfunctional State

Epigenetic Control of Cdkn2a.Arf Protects Tumor-Infiltrating Lymphocytes from Metabolic Exhaustion

TCF‐1 maintains CD8+ T cell stemness in tumor microenvironment

A Burned-Out CD8+ T-cell Subset Expands in the Tumor Microenvironment and Curbs Cancer Immunotherapy

An intra-tumoral niche maintains and differentiates stem-like CD8 T cells

A Distinct Gene Module for Dysfunction Uncoupled from Activation in Tumor-Infiltrating T Cells

Conserved transcriptional connectivity of regulatory T cells in the tumor microenvironment informs new combination cancer therapy strategies